Pilot Study of Seizure Prophylaxis With Levetiracetam in Aneurysmal Subarachnoid Hemorrhage

Trial Profile

Pilot Study of Seizure Prophylaxis With Levetiracetam in Aneurysmal Subarachnoid Hemorrhage

Withdrawn prior to enrolment
Phase of Trial: Phase IV

Latest Information Update: 03 Nov 2017

At a glance

  • Drugs Levetiracetam (Primary)
  • Indications Seizures; Subarachnoid haemorrhage
  • Focus Therapeutic Use
  • Acronyms SPLASH
  • Most Recent Events

    • 30 Oct 2017 Planned End Date changed from 1 Dec 2014 to 2 May 2013.
    • 30 Oct 2017 Planned primary completion date changed from 1 Sep 2014 to 2 May 2013.
    • 30 Oct 2017 Planned initiation date changed from 1 Jan 2014 to 1 May 2013.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top